company background image
SOLA

Solara Active Pharma Sciences NSEI:SOLARA Stock Report

Last Price

₹384.10

Market Cap

₹13.8b

7D

1.8%

1Y

-77.7%

Updated

14 Aug, 2022

Data

Company Financials +
SOLARA fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance0/6
Financial Health3/6
Dividends0/6

SOLARA Stock Overview

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India.

Solara Active Pharma Sciences Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Solara Active Pharma Sciences
Historical stock prices
Current Share Price₹384.10
52 Week High₹1,749.00
52 Week Low₹320.00
Beta0.49
1 Month Change8.11%
3 Month Change-13.54%
1 Year Change-77.67%
3 Year Change-8.45%
5 Year Changen/a
Change since IPO52.57%

Recent News & Updates

Aug 03
Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Does the August share price for Solara Active Pharma Sciences Limited ( NSE:SOLARA ) reflect what it's really worth...

Shareholder Returns

SOLARAIN PharmaceuticalsIN Market
7D1.8%-0.4%1.4%
1Y-77.7%-12.8%8.2%

Return vs Industry: SOLARA underperformed the Indian Pharmaceuticals industry which returned -12.8% over the past year.

Return vs Market: SOLARA underperformed the Indian Market which returned 8.1% over the past year.

Price Volatility

Is SOLARA's price volatile compared to industry and market?
SOLARA volatility
SOLARA Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: SOLARA is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: SOLARA's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20172,254Jithesh Devendrahttps://www.solara.co.in

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support.

Solara Active Pharma Sciences Limited Fundamentals Summary

How do Solara Active Pharma Sciences's earnings and revenue compare to its market cap?
SOLARA fundamental statistics
Market Cap₹13.83b
Earnings (TTM)-₹1.25b
Revenue (TTM)₹11.93b

1.2x

P/S Ratio

-11.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SOLARA income statement (TTM)
Revenue₹11.93b
Cost of Revenue₹7.25b
Gross Profit₹4.68b
Other Expenses₹5.93b
Earnings-₹1.25b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-34.65
Gross Margin39.22%
Net Profit Margin-10.45%
Debt/Equity Ratio67.9%

How did SOLARA perform over the long term?

See historical performance and comparison